Skip to main content
Joseph Mace, MD, Oncology, Saint Petersburg, FL

JosephRonaldMaceMD

Oncology • Saint Petersburg, FL

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Physician

Join to view full profile

Dr. Mace is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mace's full profile

Already have an account?

  • Office

    1201 5th Ave N
    Ste 505
    Saint Petersburg, FL 33705
    Phone+1 727-821-0017
    Fax+1 727-502-8861

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 1999 - 2002
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityResidency, Internal Medicine, 1996 - 1999
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Radiology-Diagnostic, 1994 - 1996
  • St Joseph's Health
    St Joseph's HealthInternship, Transitional Year, 1993 - 1994
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1993

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2025
  • NY State Medical License
    NY State Medical License 1999 - 2004
  • MI State Medical License
    MI State Medical License 1998 - 2003
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediat... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Lucio N. Gordan, MD Discusses Findings of Phase 3 Clinical Trial Supporting Advanced Treatments for Multiple Myeloma in National Broadcast
    Lucio N. Gordan, MD Discusses Findings of Phase 3 Clinical Trial Supporting Advanced Treatments for Multiple Myeloma in National BroadcastApril 26th, 2024

Dr. Joseph Mace, Dr. Joseph Mace, MD, Dr. J Mace, Dr. Joseph Ronald Mace